-
Zepbound vs Wegovy for Weight Loss- What’s the Difference?
One of the most common questions around GLP-1 medications for newbies and experienced users alike: What is the difference between Zepbound and Wegovy? Here’s an explainer! Feature Zepbound Wegovy How it Works Dual GIP and GLP-1 receptor agonist GLP-1 receptor agonist Other Names for the Same Medication TirzepatideMounjaro SemaglutideOzempic Weight Loss Efficacy Superior (average 20.2%…
-
GLP-1 Side Effects – New Study: Do GLP-1s Cause Dizziness?
GLP-1 medications have emerged as powerful tools in managing conditions like type 2 diabetes and obesity, offering significant benefits for many. These medications, known scientifically as glucagon-like peptide-1 receptor agonists (often shortened to GLP-1 RAs or GLP-1 agonists), work by mimicking a natural hormone in your body that helps regulate blood sugar levels and influences…
-
Should You Be Taking Vitamin Supplements While on GLP-1?
GLP-1 medications have been a game-changer for many, offering powerful support in managing blood sugar management and achieving weight loss. As you embark on this journey, it’s natural to wonder about every aspect of your well-being, including your nutritional needs. It’s natural to wonder about every aspect of your well-being, including your nutritional needs and…
-
Ever Wondered – Do You Lose Weight While You Sleep?
Key Points from this Post – You do lose a small amount of weight while you sleep, primarily by exhaling carbon dioxide and water vapor, as your body performs basic metabolic functions and loses some water. – Getting enough sleep is crucial for weight management because lack of sleep disrupts hormones that control appetite and…
-
GLP-1 Insurance – Why Employers Should Cover GLP-1s
Key Points from this Post – While the initial cost of GLP-1 medications like Zepbound and Wegovy is high, recent findings suggest that employer GLP-1 insurance coverage can lead to lower overall healthcare costs in the long run by reducing expenses associated with treating obesity-related chronic conditions such as diabetes and heart disease. – Providing…
-
Weight Loss Plateaus – How Long Until You Hit One?
Key Points from this Post – A weight loss plateau, where weight loss stalls despite continued effort, is a normal and common phase in a weight loss journey, not a sign of failure. – Research suggests that while plateaus eventually occur with any method, they might typically happen around 12 months with diet restriction alone,…
-
Zepbound Benefits for your Health – Beyond Weight Loss
Weight Loss Encouragement Emails Zepbound Benefits – Have we stumbled upon miracle drugs with GLP-1s? The landscape of modern medicine is perpetually shifting, driven by relentless research and groundbreaking discoveries. In recent years, a particular class of medications, known as GLP-1 receptor agonists (GLP-1 RAs), has surged to prominence, initially lauded for their remarkable effectiveness…
-
Mounjaro Fatigue and Fatigue Related Side Effects
Key Points from this Post (aka TLDR 😊) – Use of Mounjaro as a type 2 diabetes treatment and weight loss drug, like all drugs can result in adverse effects. – Mounjaro is a GLP-1 receptor agonists that can make some patients feel more tired or weak. – Fatigue may be a biproduct of how Mounjaro…
-
Do GLP-1 Medications Cause Gastrointestinal Bloating?
Navigating the GLP-1 Journey: Understanding and Managing Bloating Key Points from this Post (aka TLDR 😊) – GLP-1 medications like Zepbound are powerful tools for weight management and health, but they commonly cause gastrointestinal side effects, including uncomfortable GLP-1 bloating and abdominal pain, which can significantly impact daily life. – This bloating is primarily due…
-
Taking Zepbound Long Term – My Year 2 Weight Loss
Key Points from this Post (aka TLDR 😊) – After years of struggling with weight and trying various diets unsuccessfully, I started Zepbound (tirzepatide) and have lost 107 pounds over two years, finding it effective in managing appetite (“food noise”) and supporting significant weight loss. – My first year focused on titrating the Zepbound dose…